Role of calcitonin gene-related peptide and brain natriuretic peptide to modulate the excitability state of trigeminal neurons: relevance to migraine pathology and treatment

作者: Andrea Nistri , Sandra Vilotti , Elsa Fabbretti

DOI: 10.2147/JRLCR.S50993

关键词:

摘要: Hyperactivity of trigeminal sensory neurons is a major process to generate recurrent headache, typical migraine attacks. How physiological nociception converted into strong pathological pain remains, however, poorly understood. In recent years, certain neuropeptides and their receptors have been shown modulate neuron contribute the persistent hyperalgesia due stimulus sensitization that defines clinical experience chronic syndromes, including migraine. Using calcitonin gene-related peptide (CGRP) brain natriuretic (BNP) as examples, this review addresses mechanisms through which might nociceptor activity. One attractive notion signaling by potently regulated ambient levels these peptides: CGRP thought facilitate neuronal firing responsible for sensitiza - tion necessary trigger whereas BNP proposed act negative regulator For either peptide, key target appears be ATP-gated P2X3 receptor that, widely expressed neurons, generates fast, large excitation release glutamate onto second-order neurons. The fine balance between activities peptides suggested ultimately determine whether perceived at higher center or response. Hence, goal antagonism using pharmacological blockers monoclonal antibodies (to sequester directly inhibit its receptor) currently considered novel approach prophylaxis treat acute headache

参考文章(140)
Lincoln R. Potter, Andrea R. Yoder, Darcy R. Flora, Laura K. Antos, Deborah M. Dickey, Natriuretic peptides: their structures, receptors, physiologic functions and therapeutic applications. Handbook of experimental pharmacology. pp. 341- 366 ,(2009) , 10.1007/978-3-540-68964-5_15
Eric L Moore, Christopher A Salvatore, Targeting a family B GPCR/RAMP receptor complex: CGRP receptor antagonists and migraine. British Journal of Pharmacology. ,vol. 166, pp. 66- 78 ,(2012) , 10.1111/J.1476-5381.2011.01633.X
Geoffrey E. Woodard, Juan A. Rosado, Chapter 3 Natriuretic Peptides in Vascular Physiology and Pathology International Review of Cell and Molecular Biology. ,vol. 268, pp. 59- 93 ,(2008) , 10.1016/S1937-6448(08)00803-4
B. Fioretti, L. Catacuzzeno, L. Sforna, M. B. Gerke-Duncan, A. M. J. M. van den Maagdenberg, F. Franciolini, M. Connor, D. Pietrobon, Trigeminal ganglion neuron subtype-specific alterations of CaV2.1 calcium current and excitability in a Cacna1a mouse model of migraine The Journal of Physiology. ,vol. 589, pp. 5879- 5895 ,(2011) , 10.1113/JPHYSIOL.2011.220533
Lincoln, R. Potter, Domain analysis of human transmembrane guanylyl cyclase receptors: implications for regulation Frontiers in Bioscience. ,vol. 10, pp. 1205- 1220 ,(2005) , 10.2741/1613
Dan Levy, Migraine Pain and Nociceptor Activation-Where Do We Stand? Headache: The Journal of Head and Face Pain. ,vol. 50, pp. 909- 916 ,(2010) , 10.1111/J.1526-4610.2010.01670.X
Angelita Tottene, Rossella Conti, Alessandra Fabbro, Dania Vecchia, Maryna Shapovalova, Mirko Santello, Arn M.J.M. van den Maagdenberg, Michel D. Ferrari, Daniela Pietrobon, Enhanced Excitatory Transmission at Cortical Synapses as the Basis for Facilitated Spreading Depression in CaV2.1 Knockin Migraine Mice Neuron. ,vol. 61, pp. 762- 773 ,(2009) , 10.1016/J.NEURON.2009.01.027
Simon Akerman, Philip R. Holland, Michele P. Lasalandra, Peter J. Goadsby, Inhibition of trigeminovascular dural nociceptive afferents by Ca2+-activated K+ (MaxiK/BKCa) channel opening Pain. ,vol. 151, pp. 128- 136 ,(2010) , 10.1016/J.PAIN.2010.06.028
Marie-Luise Sixt, Karl Messlinger, Michael J. M. Fischer, Calcitonin gene-related peptide receptor antagonist olcegepant acts in the spinal trigeminal nucleus. Brain. ,vol. 132, pp. 3134- 3141 ,(2009) , 10.1093/BRAIN/AWP168